StockData
Biogen Inc. logo

Biogen Inc.

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3058% above fair value
$249.59+2.46 (+1.00%)

Close on Nov 20, 2026Market cap $36.89BP/E 106.7Yield –

Biogen Net Cash Flow from Operating Activities by Quarter

Net Cash Flow from Operating Activities ($M)

Biogen Net Cash Flow from Operating Activities: $641M in Q3 2026, down 49.6% from a year earlier.

Latest, Q3 2026
641
Period ended Sep 30, 2026
Change on a year earlier
-49.6%
1,273 in Q3 2025
History
67 quarters
Since Q3 2008
Sources
58
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Biogen Form 10-Q (filed 2026-10-28) ↗

Reported in SEC Form 10-Q / Form 10-K (GAAP Consolidated Financial Statements).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Cash Flow from Operating Activities ($M)Year on yearSource
Q3 2026Sep 30, 2026641-49.6%Biogen Form 10-Q (filed 2026-10-28) ↗
Q2 2026Jun 30, 2026449+179.0%Biogen Form 10-Q (filed 2026-07-29) ↗
Q1 2026Mar 31, 2026646+148.9%Biogen Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025512-32.7%Biogen Form 10-K (filed 2026-02-06) ↗
Q3 2025Sep 30, 20251,273+36.0%Biogen Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025161-74.3%Biogen Form 10-Q (filed 2025-07-31) ↗
Q1 2025Mar 31, 2025259-53.1%Biogen Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 2024761+5,987.2%Biogen Form 10-K (filed 2025-02-12) ↗
Q3 2024Sep 30, 2024936+57.9%Biogen Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024626+28.5%Biogen Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 2024553+21.5%Biogen Form 10-Q (filed 2024-04-24) ↗
Q4 2023Dec 31, 202312.5-107.1%Biogen Form 10-K (filed 2024-02-14) ↗
Q3 2023Sep 30, 2023592-10.4%Biogen Form 10-Q (filed 2023-11-08) ↗
Q2 2023Jun 30, 2023487-33.9%Biogen Form 10-Q (filed 2023-07-25) ↗
Q1 2023Mar 31, 2023455+181.4%Biogen Form 10-Q (filed 2023-04-25) ↗
Q4 2022Dec 31, 2022-175-120.9%Biogen Form 10-K (filed 2023-02-15) ↗

Breakdown

What makes up net Cash Flow from Operating Activities

Cite this data

StockData. (2026). Biogen Net Cash Flow from Operating Activities ($M), quarterly Q3 2008–Q3 2026 [Data set]. Compiled from Biogen SEC filings and investor materials. https://stockdatahq.com/stocks/biib/kpis/db-ocf

See every metric in the Biogen KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?